Cardiovascular / Metabolic Coverage and Expertise

Obesity, diabetes, hypertension and dyslipidemia are increasing at alarming rates, alongside parallel increases in the incidence and prevalence of many associated cardiometabolic complications such as stroke, heart failure, renal and liver disease. With varying physician specialties responsible for each disease state, this presents additional complexities when determining optimal holistic treatment choices. Chronic kidney disease (CKD) and non-alcoholic steatohepatitis (NASH) currently offer no approved therapy options often resulting in physicians aiming to treat the underlying cause of disease via comorbidities. Conversely, diabetes has seen a proliferation of therapeutic options enter the market resulting in a myriad of treatment pathways or, in some patient cases, treatment inertia.

Multimorbidity creates additional burden and complexity in disease management to both the physician and patient thus impacting associated outcomes. Our cardiometabolic evidence can offer real-world insights to these challenges alongside physician and patient-reported experiences, healthcare resource utilization, current patient management and any future treatment needs. The homogeneity of our approach allows for thematic analysis across cardiometabolic diseases, across geographies and over time.

Coronavirus (COVID-19)

As we deal with the current COVID-19 pandemic, we would like to assure you that Adelphi Group are taking every step to ensure the safety and wellbeing of all our staff, families, friends and communities. All staff worldwide are working from home and following individual Government Stay at Home guidelines to do all we can to Protect the Health Services and Save Lives. (UK : https://www.gov.uk/coronavirus) We will continue to exercise ‘Business as Usual’ to ensure our work for all continues. Indeed at the beginning of this month we held an extremely successful all work from home day to test our systems and ability to continue to communicate and deliver for whatever may happen in our world. Little did we know at the time how timely this was to be, and this will be an annual business continuity measure going forward. We would also like to share with you a programme ‘I AM PATIENT‘ produced by one of our Associate Companies, Snow, emphasising the importance of pro-actively following these critically important guidelines and to take personal responsibility to help stop the spread of this deadly virus https://www.youtube.com/watch?v=jZs-F2620CI #iampatient, #stayhome Stay Safe